Trial intelligence / Profile preview

Pharmacogenetic Effects of Salbutamol on Cycling Performance

NCT01903785Phase 4Completed

Sponsor
University of British Columbia
Start
May 2013
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of salbutamol in bronchoconstriction, sponsored by University of British Columbia. Started May 2013; status: completed.

02

Drugs

salbutamol
03

Conditions

bronchoconstriction

Beyond the preview

Go deeper on NCT01903785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01903785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call